International audienceABSTRACT : INTRODUCTION : Early randomized clinical trials of autologous bone marrow cardiac stem cell therapy have reported contradictory results highlighting the need for a better evaluation of protocol designs. This study was designed to quantify and compare whole body and heart cell distribution after intracoronary or peripheral intravenous injection of autologous bone marrow mononuclear cells in a porcine acute myocardial infarction model with late reperfusion. METHODS : Myocardial infarction was induced using balloon inflation in the left coronary artery in domestic pigs. At seven days post-myocardial infarction, 1 x 10(8) autologous bone marrow mononuclear cells were labeled with fluorescent marker and/or 99mTc ...
OBJECTIVES: To determine the safety of intramyocardial injection of autologous bone marrow cells in ...
<p><strong>BACKGROUND</strong>: Myocardial infarction (MI) is an irreversible cardiomyocytes injury ...
Background: Stem cell therapy can facilitate cardiac repair after healed myocardial infarction but t...
International audienceABSTRACT : INTRODUCTION : Early randomized clinical trials of autologous bone ...
ObjectiveThis study aimed to test the distribution of intramyocardially injected cells in variations...
ObjectivesCell therapy improved cardiac function after a myocardial infarction in several preclinica...
International audienceAIMS: Intracoronary administration of autologous bone marrow cells (BMCs) lead...
International audienceEvaluation of: Williams AR, Trachtenberg B, Velazquez DL et al. Intramyocardia...
Ph.D. University of Hawaii at Manoa 2011.Includes bibliographical references.Over the past decade th...
BACKGROUND: Recent studies report that intracoronary administration of autologous bone marrow mononu...
Background: Cell therapy approaches for biologic cardiac repair hold great promises, although basic ...
OBJECTIVES: To determine the safety of intramyocardial injection of autologous bone marrow cells in ...
<p><strong>BACKGROUND</strong>: Myocardial infarction (MI) is an irreversible cardiomyocytes injury ...
Background: Stem cell therapy can facilitate cardiac repair after healed myocardial infarction but t...
International audienceABSTRACT : INTRODUCTION : Early randomized clinical trials of autologous bone ...
ObjectiveThis study aimed to test the distribution of intramyocardially injected cells in variations...
ObjectivesCell therapy improved cardiac function after a myocardial infarction in several preclinica...
International audienceAIMS: Intracoronary administration of autologous bone marrow cells (BMCs) lead...
International audienceEvaluation of: Williams AR, Trachtenberg B, Velazquez DL et al. Intramyocardia...
Ph.D. University of Hawaii at Manoa 2011.Includes bibliographical references.Over the past decade th...
BACKGROUND: Recent studies report that intracoronary administration of autologous bone marrow mononu...
Background: Cell therapy approaches for biologic cardiac repair hold great promises, although basic ...
OBJECTIVES: To determine the safety of intramyocardial injection of autologous bone marrow cells in ...
<p><strong>BACKGROUND</strong>: Myocardial infarction (MI) is an irreversible cardiomyocytes injury ...
Background: Stem cell therapy can facilitate cardiac repair after healed myocardial infarction but t...